PORTLAND, Ore., Oct. 13, 2008 (GLOBE NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a company seeking to discover new drugs using an improved discovery process combining advanced zebrafish technologies and medicinal chemistry, today announced that it has agreed to sell, and certain officers and directors of the company agreed to purchase, the number of shares equal to the aggregate offering price of $50,000 divided by the last sale price of the company's common stock on October 16, 2008.
